![Paul Stone](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Stone
Direttore operativo presso 5AM Venture Management LLC
Patrimonio netto: 4 M $ in data 31/05/2024
Provenienza dei contatti di primo grado di Paul Stone
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
University of Wisconsin
770
| College/University | Other Consumer Services | 770 |
5AM Venture Management LLC
![]() 5AM Venture Management LLC Investment ManagersFinance 5AM Venture Management LLC (5AM Ventures) is an Independent Venture Capital firm founded in 2002 by Andrew J. Schwab, Carin M. Rollins and John D. Diekman. The firm is headquartered in San Francisco, US.
50
| Private Company | Investment Managers | 50 |
Public Company | Pharmaceuticals: Major | 19 | |
Public Company | Pharmaceuticals: Other | 13 | |
Symyx Technologies, Inc.
![]() Symyx Technologies, Inc. Packaged SoftwareTechnology Services Symyx Technologies, Inc. develops and applies high-throughput experimentation to the discovery of materials for chemical and petrochemical, pharmaceutical development, electronics, consumer goods and automotive customers. The company works together with companies seeking to transform their search for better products and processes through research collaborations and Discovery Tools sales and the license of materials, intellectual property and software. The company was incorporated in February 1999 and is headquartered in Sunnyvale, CA.
9
| Extinct | Packaged Software | 9 |
Ilypsa, Inc.
![]() Ilypsa, Inc. BiotechnologyHealth Technology Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA.
7
| Holding Company | Biotechnology | 7 |
Extinct | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Paul Stone tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Mason Street Advisors LLC
![]() Mason Street Advisors LLC Investment ManagersFinance Mason Street Advisors LLC (MSA) is a SEC-registered investment advisor headquartered in Milwaukee, Wisconsin. The firm was founded in 2001 and is a wholly owned subsidiary of the Northwestern Mutual Life Insurance Co. MSA provides professional portfolio management services for institutional investors by providing continuous investment advice and management based upon the individual needs and objectives of each client. | Investment Managers | Portfolio Manager-Fixed Income Analyst-Fixed Income | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Morgan Dempsey Capital Management LLC
![]() Morgan Dempsey Capital Management LLC Investment ManagersFinance Morgan Dempsey Capital Management LLC (Morgan Dempsey) is a SEC-registered investment advisor headquartered in Menomonee Falls, Wisconsin. The firm was founded by R. Thomas Dempsey in 1994 and is wholly-owned by MDCM Holdings LLC, which is majority owned by MDCM Legacy LLC. Morgan Dempsey manages assets for institutions, individual investors, and Registered Investment Advisors. | Investment Managers | Chief Investment Officer Director of Research - Equity | |
MYOKARDIA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
Purigen Biosystems, Inc.
![]() Purigen Biosystems, Inc. BiotechnologyHealth Technology Purigen Biosystems, Inc. engages in extracting, enriching and quantifying DNA and RNA from biological samples. The company was founded in 2012 by Amy Hiddessen, Klint Rose and Juan Santiago and is headquartered in Pleasanton, CA. | Biotechnology | Director/Board Member Director/Board Member Chairman Director/Board Member | |
Sofinnova Investments, Inc.
![]() Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Graduate Degree Undergraduate Degree | |
University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
The Brigham & Women's Hospital, Inc.
![]() The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal Chairman | |
University of California, Los Angeles | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
SV Health Investors LLC
![]() SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Investor | |
Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
Boston College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Princeton University | College/University | Director/Board Member Doctorate Degree Undergraduate Degree | |
University of California San Diego | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
University of Calgary | College/University | Graduate Degree Undergraduate Degree | |
INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Soft Switching Technologies Corp.
![]() Soft Switching Technologies Corp. Electronic Equipment/InstrumentsElectronic Technology Soft Switching Technologies Corp. provides power quality and monitoring solutions for the automated industrial markets. The firm offers scalable, battery-free DySC products, voltage sag detectors and I-Sense intelligent sensors to semiconductor, food and beverage, and automotive industries, as well as manufacturing customers and utility industries. The firm's customers include both middle market firms and blue chip companies. The company was founded by Deepak M. Divan in 1995 and is headquartered in Middleton, WI. | Electronic Equipment/Instruments | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
BIOCOM
![]() BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
Robert W. Baird & Co., Inc.
![]() Robert W. Baird & Co., Inc. Investment ManagersFinance Robert W. Baird & Co., Inc. operates as a wealth management, capital markets, private equity and asset management firm. It offers equity research, corporate restructuring, mergers and acquisitions, public financing and fixed income services. The firm serves individual, corporate, institutional and municipal clients. The company was founded by Robert Wilson Baird in 1919 and is headquartered in Milwaukee, WI. | Investment Managers | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
RELYPSA INC | Pharmaceuticals: Major | Chairman Founder Founder | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal | |
RareCyte, Inc.
![]() RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Medical Specialties | Director/Board Member Chief Executive Officer Director/Board Member | |
Cleave Therapeutics, Inc.
![]() Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Precision NanoSystems, Inc.
![]() Precision NanoSystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Precision NanoSystems, Inc. manufactures equipment related to testing electricity and electrical Signals. It develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. The company was founded by Robert James Taylor and Euan Ramsay in 2010 and is headquartered in Vancouver, Canada. | Electronic Equipment/Instruments | Director/Board Member Chairman Director/Board Member Chairman | |
EDITAS MEDICINE, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member General Counsel | |
NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Chairman Director/Board Member | |
AKOUOS | Biotechnology | Director/Board Member Chairman | |
Antimicrobials Working Group
![]() Antimicrobials Working Group Miscellaneous Commercial ServicesCommercial Services Antimicrobials Working Group is an American nonprofit company. The firm operates as an association of antimicrobials and diagnostics companies. The company says this about itself: AWG was founded in 2012 with the vision of utilizing collective power to improve the regulatory, investment, and commercial environment for emerging infectious disease companies. Today, AWG is comprised of thirteen antimicrobials companies: Acurx Pharmaceuticals, Inc., Cidara Therapeutics Inc., CorMedix Inc., Crestone, Inc., Entasis Therapeutics Inc., Iterum Therapeutics Ltd., Melinta Therapeutics LLC, Nabriva Therapeutics US Inc., Paratek Pharmaceuticals Inc., Qpex Biopharma, Inc., SCYNEXIS Inc., UTILITY therapeutics Ltd., and Venatorx Pharmaceuticals, Inc. | Miscellaneous Commercial Services | Chairman Chairman | |
Rallybio LLC
![]() Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
5AM Opportunities I GP LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
TARSUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kinaset Therapeutics, Inc.
![]() Kinaset Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kinaset Therapeutics, Inc. engages in the provision of pharmaceutical services. It develops therapeutics for intractable diseases including severe asthma. The company was founded by Robert Clarke, Roger Heerman, and Frazer Morgan and is headquartered in Medfield, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
501 ACQU | Financial Conglomerates | Chief Executive Officer Director of Finance/CFO Chief Executive Officer General Counsel | |
Ensoma, Inc.
![]() Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | Founder Chairman | |
Biotech Connection-Bay Area, Inc. | Director/Board Member General Counsel | ||
5am Partners Vi LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
RALLYBIO CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
GlycoEra AG
![]() GlycoEra AG BiotechnologyHealth Technology GlycoEra AG is a Swiss biotechnology company specializing in the development of novel biologics for various indications. The company is based in Schlieren, Switzerland, and the USA. The company utilizes its innovative customglycan platform to design, engineer, and develop medicines based on deep expertise in glycobiology. GlycoEra has raised over $49 million in a 2021 series A financing round co-led by 5AM Ventures, Sofinnova Partners, and Roche Venture Fund. The company was founded by Dominique Sirena, Amir Faridmoayer, and Veronica Gambillara Fonck. Ganesh Venkataraman Kaundinya has been the CEO of the company since 2020. | Biotechnology | Director/Board Member Director/Board Member | |
ENLIVEN THERAPEUTICS, INC. | Biotechnology | Director/Board Member General Counsel |
Statistiche
Distribuzione geografica
Stati Uniti | 47 |
Canada | 3 |
Irlanda | 2 |
Svizzera | 2 |
Settori
Health Technology | 22 |
Consumer Services | 11 |
Finance | 10 |
Commercial Services | 5 |
Electronic Technology | 3 |
Posizioni
Director/Board Member | 324 |
Corporate Officer/Principal | 177 |
Independent Dir/Board Member | 96 |
Undergraduate Degree | 90 |
Chairman | 72 |
Contatti più connessi
Insiders | |
---|---|
Andrew Schwab | 45 |
Scott Rocklage | 32 |
Kush Parmar | 32 |
Jay Shepard | 30 |
John Diekman | 29 |
Daniel Burgess | 28 |
Catherine Mackey | 24 |
Gregory H. Sachs | 23 |
Susan Kelley | 22 |
Brian Daniels | 20 |
Wendy Yarno | 19 |
Scott Morrison | 16 |
Theodore Schroeder | 16 |
Arthur Tzianabos | 15 |
June Lee | 14 |
- Borsa valori
- Insiders
- Paul Stone
- Connessioni Società